biomedicina slovenica


pr=Alessi : 15

  1. Reulen Raoul C.; Bright Chloe J.; Winter David L.; Alessi Daniela; Allodji Rodrigue S.; Bagnasco Francesca; Bárdi Edit; Bautz Andrea; Byrne Julianne; Zadravec-Zaletel Lorna
    Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe
    2021
  2. Feijen Elisabeth Arnoldina Maria; Dalen Elvira C. van; Pal Helena van der; Reulen Raoul C.; Winter David L.; Keuhni Claudia E.; Morsellino Vera; Alessi Daniela; Allodji Rodrigue S.; Zadravec-Zaletel Lorna
    Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors
    2021
  3. Byrne Julianne; Alessi Daniela; Allodji Rodrigue S.; Bagnasco Francesca; Bárdi Edit; Bautz Andrea; Bright Chloe J.; Diallo Ibrahima; Fidler Miranda M.; Zadravec-Zaletel Lorna
    The PanCareSurFup consortium
    2018
  4. Allodji Rodrigue S.; Hawkins Mike M.; Bright Chloe J.; Fidler-Benaoudia Miranda M.; Winter David L.; Alessi Daniela; Fresneau Brice; Journy Neige; Morsellino Vera; Zadravec-Zaletel Lorna
    Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe
    2019
  5. Bright Chloe J.; Hawkins Mike M.; Winter David L.; Alessi Daniela; Allodji Rodrigue S.; Bagnasco Francesca; Bárdi Edit; Bautz Andrea; Byrne Julianne; Zadravec-Zaletel Lorna
    Risk of soft-tissue sarcoma among 69 460 five-year survivors of childhood cancer in Europe
    2018
  6. Grabow Desiree; Kaiser Melanie; Hjorth Lars; Byrne Julianne; Alessi Daniela; Allodji Rodrigue S.; Bagnasco Francesca; Bárdi Edit; Bautz Andrea; Bright Chloe J.; Zadravec-Zaletel Lorna
    The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer
    2018
  7. Feijen Elisabeth A. M.; Font-Gonzalez Anna; Reulen Raoul C.; Winter David L.; Kuehni Claudia E.; Haupt Riccardo; Alessi Daniela; Byrne Julianne; Bárdi Edit; Zadravec-Zaletel Lorna
    Late cardiac events after childhood cancer
    2016
  8. Juhan-Vague I; Alessi MC; Mavri A; Morange PE
    Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
    2003
  9. Bastelica D; Mavri A; Verdierl M; Berthet B; Juhan-Vague I; Alessi MC
    Relationships between fibrinolytic and inflammatory parameters in human adipose tissue: strong contribution of TNFalpha receptors to PAI-1 levels
    2002
  10. Mavri A; Bastelica D; Poggi M; Morange P; Peiretti F; Verdier M; Juhan-Vague I; Alessi MC
    Polymorphism A36G of the tumor necrosis factor receptor 1 gene is associated with PAI-1 levels in obese women
    2007
  11. Alessi Marie-Christine; Bastelica Delphine; Mavri Alenka; Morange Pierre; Berthet Bruno; Grino Michel; Juhan-Vague Irene
    Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation
    2003
  12. Mavri A; Alessi MC; Juhan-Vague I
    Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases
    2004
  13. Mavri Alenka; Bastelica Delphine; Staels Bart; El Ayachi Soulaf; Juhan-Vague Irene; Alessi Marie-Christine
    PPARalpha deficiency does not modify age dependency but prevents high fat diet increase in plasma PAI-1 as well as insulin resistance
    2004
  14. Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentočnik JT; Stegnar M; Juhan-Vague I
    Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss
    2001
  15. Juhan-Vague I; Alessi MC; Morange PE
    Hypofibrinolysis and increased PAI-I are linked to atherothrombosis via insulin resistance and obesity
    2001


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics